Inflammatory Bowel Disease and Familial Adenomatous Polyposis

Clinical Management and Patients’ Quality of Life

  • Gian Gaetano Delaini

Table of contents

  1. Front Matter
    Pages I-XIX
  2. General Approach

    1. Front Matter
      Pages 1-1
    2. Riccardo Manfredi, Roberto Malagò, Marco Testoni, Veronica Girardi, Roberto Pozzi Mucelli
      Pages 3-11
  3. Inflammatory Bowel Disease

    1. Front Matter
      Pages 13-13
    2. Gabriele Riegler, Annalisa de Leone
      Pages 15-22
    3. Emil Salmo, Shamim Absar, Najib Haboubi
      Pages 23-34
    4. Emil Salmo, Patrick O’Connolly, Najib Haboubi
      Pages 35-44
    5. Gabriele Riegler, Ilaria Esposito
      Pages 45-49
    6. Beatrice Salvioli, Gabriele Bazzocchi
      Pages 51-59
    7. Giacomo C. Sturniolo, Michela Barollo, Renata D’Incà
      Pages 61-72
    8. Giulio Aniello Santoro, Marianne Starck, Luca Campana, Bjørn Fortling
      Pages 73-87
    9. Andrea Ederle, Paolo Inturri, Piero Brosolo, Alberto Fantin, Monica Preto
      Pages 89-99
    10. Giampaolo Angelini, Laura Bernardoni
      Pages 101-106
    11. Italo Vantini, Fosca De Iorio, Naika Tacchella, Luigi Benini
      Pages 107-119
    12. Paolo Gionchetti, Fernando Rizzello, Claudia Morselli, Rosy Tambasco, Massimo Campieri
      Pages 121-125
    13. Gianluca Colucci, Gian Gaetano Delaini, Filippo Nifosì
      Pages 133-140
    14. Luigi Zorcolo, Giuseppe Casula
      Pages 141-155
    15. Luca Frulloni, Laura Bernardoni, Chiara Scattolini, Italo Vantini
      Pages 157-170
    16. Luigi Benini, Fosca De Iorio, Naika Tacchella, Italo Vantini
      Pages 171-179

About this book


Inflammatory bowel disease (IBD) and familial adenomatous polyposis (FAP) are complex diseases, which are subject to numerous medical researches. Despite increased knowledge on the pathophysiological process, many aspects remain rather unclear, especially concerning IBD. The genetic basis of FAP is well known, but there is still debate about IBD, which seems more likely to be a multifactorial disease, where the illness is due to interactions between environmental and genetic factors. In the near future, the aim will be to prevent these disorders and their sequelae through early detection and early intervention (for example genetic therapy). Unfortunately, we are still dealing with young patients with a lifelong disease course, leading to early morbidity (and in some cases mortality) and extended needs for medical treatment, with a consequent decrease in quality of life. IBD and FAP represent a challenge for a multidisciplinary medical approach where different personnel play major roles in different stages of the patient’s treatment. It is in this light that basic scientists, geneticists, pathologists, radiologists, gastroenterologists, surgeons, psychologists and WOC/ET nurses have to work together in order to improve the outlook of these patients and their families.


Surgery cancer colectomy colon endoscopy genetics imaging inflammatory bowel disease liver liver transplantation mutation quality of life transplantation tumor ultrasonography

Editors and affiliations

  • Gian Gaetano Delaini
    • 1
  1. 1.Department of Surgery and GastroenterologyUniversity of VeronaVeronaItaly

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Italia 2006
  • Publisher Name Springer, Milano
  • eBook Packages Medicine
  • Print ISBN 978-88-470-0433-7
  • Online ISBN 978-88-470-0434-4
  • About this book